China National Pharmaceutical Industry Research Institute

The China National Pharmaceutical Industry Research Institute (CNPIRI), also known as the Shanghai Institute of Pharmaceutical Industry (SIPI), is a premier state-owned pharmaceutical R&D organization in China. Operating as a key subsidiary of Sinopharm, the institute specializes in the discovery and development of both innovative drugs and high-quality generics. CNPIRI hosts several national platforms, including the National Engineering Research Center for Pharmaceutical Preparation and the National Pharmaceutical Quality Control Center. Its expertise spans medicinal chemistry, pharmacology, formulation science, and industrialization, making it a critical hub for China's pharmaceutical innovation. The institute has successfully developed hundreds of drug varieties that have reached the commercial market through various Sinopharm subsidiaries and industry partners.